Radiotherapy-triggered proteolysis targeting chimera prodrug activation in tumors

C Yang, Y Yang, Y Li, Q Ni, J Li - Journal of the American …, 2022 - ACS Publications
Proteolysis targeting chimera (PROTAC) is an emerging protein degradation strategy, which
shows excellent advantages in targeting those so-called “undruggable” proteins. However …
被引用次数：43 相关文章

Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors

C Yang, Y Yang, Y Li, Q Ni, J Li - Journal of the American …, 2023 - pubmed.ncbi.nlm.nih.gov
Proteolysis targeting chimera (PROTAC) is an emerging protein degradation strategy, which
shows excellent advantages in targeting those so-called" undruggable" proteins. However …

Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors

C Yang, Y Yang, Y Li, Q Ni, J Li - paper.sciencenet.cn
Proteolysis targeting chimera (PROTAC) is an emerging protein degradation strategy, which
shows excellent advantages in targeting those so-called “undruggable” proteins. However …

Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors.

C Yang, Y Yang, Y Li, Q Ni, J Li - Journal of the American Chemical …, 2022 - europepmc.org
Proteolysis targeting chimera (PROTAC) is an emerging protein degradation strategy, which
shows excellent advantages in targeting those so-called" undruggable" proteins. However …